Teladoc Health, Inc.
NYSE:TDOC
9.09 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -220.368 | -13,659.531 | -428.793 | -485.136 | -98.864 | -97.084 | -106.782 | -74.216 | -58.02 | -17.037 | -6.019 |
| Depreciation & Amortization
| 351.323 | 270.643 | 219.621 | 78.087 | 44.952 | 35.602 | 19.095 | 8.27 | 4.863 | 2.32 | 0.754 |
| Deferred Income Tax
| -1.903 | -7.84 | 41.8 | -90.158 | -10.868 | -2.247 | -0.306 | 0.51 | 0.036 | 0.388 | 0.094 |
| Stock Based Compensation
| 201.55 | 217.852 | 302.586 | 475.531 | 66.702 | 43.769 | 30.597 | 7.723 | 3.075 | 0.533 | 0.298 |
| Change In Working Capital
| 11.643 | -60.971 | -50.324 | -90.483 | -0.156 | -1.13 | 0.72 | -4.473 | -0.427 | 1.023 | -1.686 |
| Accounts Receivables
| -10.252 | -61.641 | -17.51 | -21.091 | -15.884 | -10.931 | -3.659 | -2.9 | -6.795 | -5.079 | -0.928 |
| Inventory
| 24.095 | 14.8 | -19.494 | -24.732 | 10.277 | 1.712 | -0.923 | -2.448 | 4.093 | 2.032 | -0.461 |
| Accounts Payables
| -4.185 | 1.876 | 1.188 | -87.995 | 0.905 | -0.391 | 1.534 | -0.813 | -0.612 | 2.099 | -1.099 |
| Other Working Capital
| 1.985 | -16.006 | -14.508 | 43.335 | 4.546 | 8.48 | 3.768 | 1.688 | 2.887 | 1.971 | 0.802 |
| Other Non Cash Items
| 7.776 | 13,429.139 | 109.1 | 58.648 | 28.103 | 16.23 | 22.235 | 10.391 | 3.292 | 1.414 | 0.506 |
| Operating Cash Flow
| 350.021 | 189.292 | 193.99 | -53.511 | 29.869 | -4.86 | -34.441 | -51.795 | -47.181 | -11.359 | -6.053 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -156.348 | -172.764 | -63.934 | -26.042 | -10.9 | -8.407 | -5.515 | -3.412 | -7.817 | -1.734 | -1.294 |
| Acquisitions Net
| 0 | 0 | -78.663 | -567.429 | -11.187 | -282.442 | -379.356 | -37.013 | -17.767 | -13.844 | -16.462 |
| Purchases Of Investments
| 0 | 0 | 63.934 | 26.042 | -5 | -56.347 | -149.261 | -44.146 | -103.03 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 2.507 | 60.901 | 2.496 | 52.1 | 84.17 | 85.753 | 110.717 | 20.411 | 0 | 0 |
| Other Investing Activites
| 0.001 | 2.514 | -55.219 | -26.042 | 39.71 | 5.53 | -66.39 | 65.267 | -84.161 | -0.665 | -1.09 |
| Investing Cash Flow
| -156.347 | -167.743 | -72.981 | -590.975 | 25.013 | -257.496 | -448.379 | 26.146 | -108.203 | -15.578 | -17.756 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | -14.672 | -0.139 | -238.153 | -2.417 | -279.162 | -226.44 | -17.166 | -6.332 | -19.7 | -3 |
| Common Stock Issued
| 11.132 | 5.884 | 42.591 | 59.036 | 36.663 | 330.843 | 258.554 | 0.25 | 163.118 | 0 | 0 |
| Common Stock Repurchased
| -0.278 | 0 | 0 | -26.703 | -1.569 | 0 | -0.074 | 0 | 0 | -0.368 | -0.071 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 11.132 | 15.285 | -1.505 | 1,097.289 | 35.094 | 314.769 | 443.317 | 37.514 | 7.228 | 70.529 | 18.398 |
| Financing Cash Flow
| 10.854 | 6.497 | 40.947 | 859.136 | 35.094 | 645.612 | 475.431 | 20.598 | 164.014 | 70.161 | 18.327 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0.965 | -3.344 | -1.8 | 4.321 | 0.388 | -2.084 | 0.191 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 205.493 | 24.702 | 160.156 | 218.971 | 90.364 | 381.172 | -7.198 | -5.051 | 8.63 | 43.224 | -5.482 |
| Cash At End Of Period
| 1,123.675 | 918.182 | 893.48 | 733.324 | 514.353 | 423.989 | 42.817 | 50.015 | 55.066 | 46.436 | 3.212 |